TwardowskiZ., KhannaR.Peritoneal dialysis access and exit-site care. In: GokalR., NolphK.D., eds. The Textbook of Peritoneal Dialysis.Dordrecht: Kluwer Academic Publishers; 1994: 271–314.
2.
RinaldiS., SeraF., VerrinaE., EdefontiA., PerfumoF., SorinoP.The Italian Registry of Pediatric Chronic Peritoneal Dialysis: A ten years experience with chronic peritoneal dialysis catheters.Perit Dial Int.1998; 18: 71–4.
3.
LewisM., SmithT., PostlethwaiteR., WelbN.A comparison of double cuffed with single cuffed Tenckhoff catheters in the prevention of infection in pediatric patients. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1997; 13: 274–6.
4.
FurthS.L.The problem of exit site infections in pediatric PD patients. A North American Pediatric Renal Transplant Cooperative Study report. In: University of Missouri, Columbia, ed. Proceedings of the 9th Annual Pediatric Peritoneal Dialysis Symposium at the 18th Annual Conference on Peritoneal Dialysis Symposium at the 18th Annual Conference on Peritoneal Dialysis; 23–25 February 1998; Nashville, Tennessee, U.S.A.
5.
SojoE., BisignianoL., GrosmanM., BailezM.Ten years experience with CAPD catheters. In: FineR.N., WaradyB.A., AlexanderS.T., eds, CAPD/CCPD in Children.2nd ed.Dordrecht: Kluwer Academic Publishers; 1998: 263–80.
6.
KuizonB., MelocotonT.L., HollowayM., InglesS., HejingS., FonkalsrudE.W.Infectious and catheter-related complications in pediatric patients treated with peritoneal dialysis at a single institution.Pediatr Nephrol.1995; 9(Suppl): S12–17.
7.
HondaM., LitakaK., KawaguchiH., HoshiS., AkashiS., KohsaaT.The Japanese National Registry Data in pediatric CAPD patients: A report of the study group of the pediatric conference.Perit Dial Int.1996; 16: 269–75.
8.
WaradyB.A., HebertD., SullivanE.K., AlexanderS.R., TejaniA.Renal transplantation, chronic dialysis and chronic renal insufficiency in children and adolescents: The 1995 annual report of the North American Pediatric Renal Transplant Cooperative Study.Pediatr Nephol.1997; 11: 49–64.
9.
JonesL., TweedyL., WaradyB.The impact of exit site care and catheter design on the incidence of catheter related infections. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1995; 11: 302–5.
10.
WaradyB.A., SullivanE.K., AlexanderS.R.Lessons from the peritoneal dialysis patient database: A report of the North American Pediatric Renal Transplant Cooperative Study.Kidney Int.1996; 49(Suppl 53): S68–71.
11.
PenalozaJ., TurconiA., DelgadoN., FernandezG., SojoE.Incidence of PD associated peritonitis and exit site infections in children converted to y set disconnect system [Abstract].Pediatr Nephrol.1995; 9(6): C95.
12.
WarcholsS., RoszkowskaB.M., SieniawskaM.Swan neck peritoneal dialysis catheter: Five years experience in children.Perit Dial Int.1998; 18: 183–7.
TranæusA.Peritonitis in pediatrics continuous peritoneal dialysis. In: FineR.N., WaradyB.A., AlexanderS.T., eds. CAPD/CCPD in Children.2nd ed.Dordrecht: Kluwer Academic Publishers; 1998: 301–47.
15.
Pecoits-FilkoR.F.S., TwardowskiZ.J., KhannaR., KimY.L., GoelS., MooreH.The effect of antibiotic prophylaxis on the healing of exit-sites of PD catheters in rats.Perit Dial Int.1998; 18: 60–3.
16.
GrosmanM., HernandezG., MaldonadoS., BisignianoL., SojoE.Iodine povidone (10%) soap solution or hypertonic saline (3% NaCI): Which is the best for the prevention of ESI/TI in children on CAPD? A prospective randomized study [Abstract].Rev Nefrol Dial Transplant (B Aires).1998; 46(Suppl): 65.
17.
KingwatanakulP., WaradyB.Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1997; 13: 281–4.
18.
pérez-Font´nM., García-FalcónT., RosalesM., Rodrigues-CarmonaA., AdevaM., Rodiguez-LozanaI.Treatment of Staph aureus nasal carriages in CAPD with mupirocin: Long term results.Am J Kidney Dis.1993; 22: 708–12.
19.
ZimmermanS.W., AhrensE., JohnsonC.A., CraigW., LeggettS., O'BrienM.Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.Am J Kidney Dis.1991; 18: 225–31.
20.
HanevoldC.D., FisherM.C., WaltzR., BartoshS., BaluarteH.J.Effect of rifampin on Staphylococcus aureus colonization in children on chronic peritoneal dialysis.Pedriatr Nephrol.1995; 9: 609–11.
21.
Mupirocin Study Group. Nasal mupirocin prevents Staph aureus exit-site infection during peritoneal dialysis.J Am Soc Nephrol.1996; 7: 2403–8.
22.
BernardiniJ., PirainoB., HolleyJ., JohnstonJ.R., LutesR.A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.Am J Kidney Dis.1996; 27: 695–700.
23.
BloweyD.C., WaradyB.A., McFarlandK.S.The treatment of Staph aureus nasal carriage in pediatric peritoneal dialysis patients. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1994; 10: 297–9.
SchroederC.H., SeverynenR., de JongM., MonnemL.Chronic tunnel infection in children: Removal and replacement of CAPD catheter in a single operation.Perit Dial Int.1993; 13: 198–200.
26.
ProwantB.F., WaradyB.A., NolphK.D.Peritoneal dialysis catheter exit-site care: Results of an international study.Perit Dial Int.1993; 13: 149–54.
27.
NeuA.M., KohautE.C., WaradyB.A.Current approach to peritoneal access in North American children: A report of the Pediatric Peritoneal Dialysis Study Consortium. In: KhannaR., ed. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Publications, 1995; 11: 289–92.